$REGN 0.46 Noisy

Notable posts

• @wallstengine neutral 67 eng

  Today's Key Events (All EST) — 07/30/2026 08:30: US PCE Price Index 08:30: US Initial Jobless Claims 08:30: US GDP QoQ Advance 08:30: US Consumer Spending Before Open 👇 05:00: Check Point Software $CHKP 05:00: Yum China $YUMC 06:00: Cigna $CI 06:00: Enterprise Products $EPD 06:00: CRH $CRH 06:00: Air Products $APD 06:30: Valero Energy $VLO 06:30: Norwegian Cruise Line $NCLH 06:30: Regeneron $REGN 06:30: TC Energy $TRP 06:30: Xerox $XRX 06:30: Trane Technologies $TT 06:45: Hershey $HSY 06:45: TechnipFMC $FTI 06:50: KKR $KKR 06:55: Bristol Myers Squibb $BMY 06:55: Ferrari $RACE 06:55: Quanta Services $PWR 06:55: American Electric Power $AEP 07:00: Crocs $CROX 07:00: Yum! Brands $YUM 08:00: Mastercard $MA After Hours 👇 16:00: Amazon $AMZN 16:00: DexCom $DXCM 16:00: Strategy $MSTR 16:00: First Solar $FSLR 16:00: Monolithic Power Systems $MPWR 16:00: Neurocrine Biosciences $NBIX 16:00: Tempus AI $TEM 16:05: Roblox $RBLX 16:05: Reddit $RDDT 16:05: Rivian $RIVN 16:05: GoDaddy $GDDY 16:05: Illumina $ILMN 16:05: Nextpower $NXT 16:05: Stryker $SYK 16:05: Universal Display $OLED 16:10: Live Nation $LYV 16:15: MasTec $MTZ 16:15: Coinbase $COIN 16:15: BigBear .ai $BBAI 16:15: Mohawk Industries $MHK 16:30: Apple $AAPL 16:30: Corteva $CTVA 17:10: Eldorado Gold $EGO 18:55: Vale $VALE 19:00: Sony

  view on X →
• @wallstengine bullish 33 eng

  REGENERON $REGN Q2’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $4.3B (Est. $3.82B) 🟢; +17% YoY 🔹 Adj. EPS: $14.29 (Est. $10.26) 🟢; +11% YoY 🔹 Dupixent Global Net Sales: $6.0B; +38% YoY 🔹 EYLEA HD U.S. Net Sales: $596M; +52% YoY FY26 Guide: 🔹 Non-GAAP R&D: $5.95B-$6.05B; from $5.90B-$6.10B 🔹 Non-GAAP SG&A: $2.50B-$2.60B; from $2.50B-$2.65B 🔹 Non-GAAP Gross Margin: 84%-85%; from 83%-84% 🔹 Capital Expenditures: $1.03B-$1.10B; from $1.10B-$1.20B 🔹 Non-GAAP ETR: 14%-15%; from 13%-15% Segment Net Revenue: 🔹 Dupixent (Global, Sanofi-recorded): $6.0B; +38% YoY 🔹 EYLEA HD - U.S.: $596M; +52% YoY 🔹 EYLEA - U.S.: $412M; -45% YoY 🔹 Libtayo - Global: $489M; +30% YoY 🔹 Total Net Product Sales: $1.64B; +1% YoY 🔹 Sanofi Collaboration Revenue: $2.17B; +51% YoY Other Q2 Metrics: 🔹 GAAP Gross Margin (Net Product Sales): 78%; -500 bps YoY 🔹 Non-GAAP Gross Margin (Net Product Sales): 87%; +100 bps YoY 🔹 GAAP Effective Tax Rate: 15.1%; +670 bps YoY Capital Return: 🔹 Buybacks: $1.2B 🔹 Remaining Authorization: $2.5B 🔹 Dividend: $0.94/share, payable August 31, 2026 Business Highlights: 🔹 Sanofi Development Balance: Fully repaid as of end of Q2 2026 🔹 Cemdisiran (gMG): FDA and EMA accepted regulatory submissions Comments: 🔸 “Regeneron delivered another quarter of strong financial performance, with double-digit top- and bottom-line growth reflecting the continued strength of our commercial portfolio and the potential of our pipeline.” 🔸 “By the end of the second quarter, we had fully repaid the Sanofi Development Balance, which represented the outstanding amount due to Sanofi for their funding of prior collaboration development activities. The repayment of this obligation will drive a meaningful step-up in collaboration profits beginning in the third quarter.”

  view on X →
• @faststocknewss neutral 19 eng

  FDA SELECTS SEVEN COMPANIES FOR PRECHECK PILOT TO BOOST US DRUG MANUFACTURING The FDA selected seven participants for its PreCheck pilot program to advance domestic drug manufacturing, per the agency: - Amneal $AMRX - Cellares - Eli Lilly $LLY - Fujifilm - Kriya - Kyowa Kirin - Regeneron $REGN The selected companies will engage with the FDA under a two-phase PreCheck model, with early technical guidance provided in Phase 1.

  view on X →
• @tenet_research neutral 19 eng

  Tenet Market Wake-Up Summary 📷📷 July.30.26 $SPX $SPCX $IBRX $INTC $MU $SNDK $SKHY $STX $TE $RKLB $RCAT $IBM $KTOS $LDOS $CRWV $ESTC $RKTO $MSFT $META $HOOD $CMG $ARM $QCOM $CI $APD $SHEL $BLDR $BMY $HSY $MO $NCLH $PWR $REGN $RACE $VLO $YUM $HUM $SFM $BE $SKY $MIR $SMFT $MAS $CINF $WIX $XRX $SCORT $CAPR $TREE $BTC @ripster47 | @TENETTRADEGROUP | @TenetCharts

  view on X →